ENTITY

PegBio (2565 HK)

36
Analysis
Health Care • China
PegBio Co., Ltd. is a biotechnology company focused on the discovery and development of innovative therapies for chronic diseases, particularly metabolic disorders. The company develops differentiated therapeutics for conditions such as type 2 diabetes mellitus, obesity, metabolic dysfunction-associated steatohepatitis (MASH), opioid-induced constipation (OIC), and congenital hyperinsulinemia. PegBio was founded in 2008 and is headquartered in Hangzhou, Zhejiang Province, China.
more
Company Event • 22 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 25 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 23 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 26 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

No more events
x